MDS Nordion has completed its new $20-million cyclotron in Vancouver where it is co-located with TRIUMF. The cyclotron will begin producing radioisotopes in April, starting with thallium-201, which is used as a heart imaging agent. The cyclotron will double MDS Nordion’s production capacity and result in 20 new jobs....
Other stories mentioning these organizations, people and topics
| Organizations: | MDS Nordion and TRIUMF |
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.